China’s health market is no longer a future opportunity. It is happening right now, at a scale most Western brands still underestimate. I have been working with health and wellness brands entering China for over 15 years. The brands that win are the ones that understand the market before they enter it.
Current Situation of China’s Health Market
China’s healthcare sector is one of the fastest-growing globally, driven by an aging population (28% over 60 by 2040), rising middle-class demand, and government initiatives like Healthy China 2030 (targeting a market value of RMB 16 trillion by 2030). Key trends include:
- Aging Demographics: 14.9% of the population is over 65, increasing demand for chronic disease management and elderly care services.
- Healthcare Reforms: Anti-corruption campaigns and regulatory shifts (e.g., SAMR’s 2025 compliance guidelines) are reshaping procurement and compliance practices.
- Tech Integration: AI-driven drug discovery, telemedicine, and digital health platforms (e.g., Douyin for health product sales) are growing fast.
- Manufacturing Growth: China is a global leader in generics and medical device production, with plans to reduce reliance on imports via Made in China 2025.
2026 Market Update: The Numbers That Matter
The data is clear: China’s health market has crossed a threshold that demands serious attention from international brands.
The overall China healthcare market reached USD 1.55 trillion in 2026, on a trajectory toward USD 2.62 trillion by 2032 (CAGR of 9.14%). The broader health industry, including wellness, functional food, and supplementation, stood at approximately 17.4 trillion yuan in 2025 and is projected to hit 29 trillion yuan by 2030. Within that, China’s health supplement segment alone is expected to exceed RMB 400 billion in 2026, up from RMB 377.5 billion in 2025 according to iMedia Research.
These are not projections built on optimism. They reflect structural changes in how Chinese consumers think about health, age, and quality of life.
Where the Sales Are Actually Happening in 2026
In 2025, health supplement online sales split as follows: Tmall at 40.3%, Douyin at 38.8%, and JD Health at 20.9%. Douyin is catching up to Tmall fast. That shift changes everything about how brands need to operate.
I have seen brands that built their China strategy entirely around Tmall five years ago now scrambling to rebuild for Douyin. The brands that anticipated the shift are winning. At Cosmetics China Agency, we’ve worked with brands that entered Douyin early with educational content and watched their supplement sales multiply within two quarters.
The proof is in the numbers: Haleon reported 100% year-on-year growth on Douyin in Q1 2026. They did not do it by flooding the platform with influencers. They put their own scientists on livestream. That is the shift: authenticity and expertise now convert better than polish and celebrity.
On Douyin, the top five health supplement categories are collagen, vitamins and minerals, protein powder, probiotics, and beauty-from-within products. If your brand sits in any of these spaces, Douyin advertising is not optional. It is your primary channel.
Consumer Behavior Shifts: Who Is Buying and Why
Three groups are driving the 2026 growth:
- Young consumers (Gen Z): Stress, sleep, and cognitive performance are their priorities. Melatonin, adaptogens, and ergothioneine are the trending ingredients. Ergothioneine sales exceeded RMB 200 million in 2025, a sign of what is coming in 2026.
- Middle-aged urban professionals: Beauty-from-within, anti-aging, and joint health. They are premium buyers. They research on Xiaohongshu before purchasing.
- Silver generation (60+): Brain health, bone density, cardiovascular support. Strong purchasing power. Underserved by most international brands.
The premiumization trend is real for health products. Chinese consumers are trading up, not down, in this category. I’ve seen brands fail because they entered with mid-range positioning and found no market. Either you are premium with clear efficacy proof, or you compete on price and lose to domestic brands.
Xiaohongshu and WeChat: The Discovery Layer
Douyin drives impulse and discovery. But Xiaohongshu is where health product research happens. Consumers in China read reviews, watch tutorials, and look for clinical validation on XHS before they buy. A brand with strong Xiaohongshu marketing builds the trust that converts to Douyin sales.
WeChat remains critical for retention. Subscription content, loyalty programs, and personalized health advice through WeChat mini-programs keep customers coming back. If you are building a health brand in China long-term, your WeChat strategy is your CRM.
AI-powered search tools like Doubao and Kimi are also changing discovery. Younger consumers increasingly use conversational AI to find product recommendations. Brands that appear in those results are the ones with content depth, clinical claims, and consistent presence across platforms.
Top 10 Opportunities in China’s Health Market
- Traditional Chinese Medicine (TCM) Modernization
- Demand for TCM-based supplements (e.g., ginseng, Lingzhi mushrooms) and clinical validation of herbal formulas.
- Anti-Aging and Chronic Disease Management
- Products targeting diabetes, cardiovascular diseases, and neurodegenerative conditions for the aging population.
- Health Supplements and Immunity Boosters
- Probiotics, multivitamins, and adaptogens (e.g., reishi mushroom) are top-selling categories. The supplement market crosses RMB 400 billion in 2026.
- Digital Health and Telemedicine
- AI diagnostics, online consultations, and health monitoring apps (e.g., Alibaba Health). The digital health market hit USD 94.9 billion in 2025.
- Medical Devices and High-Tech Equipment
- Domestic production of advanced devices (e.g., imaging systems, in-vitro diagnostics).
- Elderly Care Services
- Home-based care solutions, nursing robots, and senior-friendly health products. The silver generation is an underserved premium segment.
- Precision Medicine and Oncology
- Personalized therapies and AI-driven drug development for cancer treatment.
- Mental Health and Wellness
- Stress-relief supplements (e.g., melatonin, ergothioneine), mindfulness apps, and TCM-based calming formulas. Gen Z demand is accelerating this category.
- Cross-Border E-Commerce for Health Products
- Platforms like Tmall Global and Douyin together account for nearly 80% of online health product sales. CBEC is the fastest entry route for foreign brands.
- Green and Sustainable Healthcare
- Eco-friendly medical devices, organic supplements, and pollution-defense skincare. Younger Chinese consumers increasingly factor sustainability into purchasing decisions.
Best-Selling Health Products in China
- Probiotics
- For gut health and immunity (e.g., Swisse, WonderLab). Consistent top-seller across all age groups.
- Multivitamins
- Broad nutrient supplements (e.g., GNC, Blackmores). Strong cross-border e-commerce performance.
- Omega-3 Fatty Acids
- Fish oil capsules for heart and cognitive health. Growing demand among the 50+ segment.
- Collagen Supplements
- Anti-aging and skin health (e.g., Florasis, Proya). Top Douyin category in 2026.
- TCM Blends
- Herbal formulas for energy (ginseng) and detox (fo-ti). Demand driven by both domestic and cross-border consumers.
- Coenzyme Q10 (CoQ10)
- Popular among seniors for cardiovascular support.
- Lingzhi (Reishi Mushroom)
- Immunity-boosting adaptogen with strong TCM heritage and modern clinical backing.
- Melatonin
- Sleep aid for urban professionals. One of the fastest-growing categories among Gen Z in 2025-2026.
- Ergothioneine
- The breakout ingredient of 2025-2026. Sales exceeded RMB 200 million in 2025. Anti-aging and antioxidant claims resonate strongly on Douyin and XHS.
- Protein Supplements
- Whey and plant-based protein, driven by the fitness and weight management trend among 25-40 year-olds.
What International Brands Need to Get Right
I’ve seen brands fail because they treated China like any other market. They launched on one platform, used the same creative as their home market, and waited. Nothing happened.
China’s health consumer is specific. They want clinical proof, transparent ingredient sourcing, and endorsement from people they trust. KOLs in the health space carry more weight than brand advertising. A KOL marketing strategy built around credible doctors, nutritionists, and fitness influencers will outperform any banner campaign.
At Cosmetics China Agency, we’ve worked with brands across probiotics, nutraceuticals, and functional food. The ones that scale are the ones that invest in content depth early: ingredient education, clinical references, real consumer stories. That content works on XHS for discovery, on Douyin for conversion, and on WeChat for retention.
The regulatory side matters too. SAMR’s 2025 compliance guidelines changed how health claims can be made online. You need to know what you can and cannot say before your content goes live. Brands that skip this step face takedowns and platform bans that cost far more than the compliance work would have.
Our digital marketing agency for China specializes in health and wellness brands entering the Chinese market. Contact us for a free audit of your China strategy.
